Lifco AB has acquired a majority stake in Rhein83 Srl
Lifco AB has acquired a majority stake in the Italian dental company Rhein83 Srl. Financial details have not been disclosed.
Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth and strong cash flows. The group is listed on Nasdaq Stockholm and has three business areas: dental, demolition & tools and systems solutions. The company has a clear corporate philosophy which implies a long-term perspective, focus on profits and a highly decentralized organization. As of today, the investment group controls circa140 companies in 30 countries, generating revenues of over US$1 billion.
Established in 1983 and located in Bologna, Italy, Rhein83 has innovated the dental market with the introduction of elastic spherical attachments (previously were only metallic) for dental implants. The company's technology is highly recognized and appreciated worldwide.
Oaklins' team in Italy advised the buyer in this transaction.
Ingvar Ljungqvist
Head of Acquisitions, Lifco AB
Talk to the deal team
Related deals
Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more